Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$11.45M
Expense Ratio	0.85%
PE Ratio	26.84
Shares Out	300,000
Dividend (ttm)	$0.23
Dividend Yield	0.59%
Ex-Dividend Date	Dec 31, 2024
Payout Frequency	n/a
Payout Ratio	16.09%

Volume	2,342
Open	38.34
Previous Close	37.95
Day's Range	38.10 - 38.40
52-Week Low	31.08
52-Week High	42.41
Beta	1.09
Holdings	46
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

38.50% of assets

Name	Symbol	Weight
The Charles Schwab Corporation	SCHW	3.94%
Mueller Water Products, Inc.	MWA	3.92%
UMB Financial Corporation	UMBF	3.92%
SmartStop Self Storage REIT, Inc.	SMA	3.91%
MasTec, Inc.	MTZ	3.88%
Sportradar Group AG	SRAD	3.86%
SkyWest, Inc.	SKYW	3.83%
Jefferson Capital, Inc.	JCAP	3.83%
Madrigal Pharmaceuticals, Inc.	MDGL	3.81%
Alphabet Inc.	GOOGL	3.61%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of 10.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.83%.